Y. He

Ginsenoside Rg1 attenuates lipopolysaccharide-induced inflammatory responses via the phospholipase C-γ1 signaling pathway in murine BV-2 microglial cells.

E. Ling, Y. Zong, Qing-long Ai, 2012, Current medicinal chemistry.

Synthesis and structure-activity relationships of pyridine-modified analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonist.

D. Donnelly-roberts, S. Arneric, J. Sullivan, 1998, Bioorganic & medicinal chemistry letters.

Synthesis and human beta-adrenoceptor activity of 1-(3,5-diiodo-4- methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-6-ol derivatives in vitro.

Y. He, D. Miller, D. Feller, 2000, Journal of medicinal chemistry.

Novel Zn and Cd Coordination Polymers Assembled from Imidazole-based Zwitterionic Ligands: Synthesis, Crystal Structures, and Luminescence Properties

G. Xiong, P. Yang, L. You, 2019, Russian Journal of Coordination Chemistry.

Ligands for brain cholinergic channel receptors: synthesis and in vitro characterization of novel isoxazoles and isothiazoles as bioisosteric replacements for the pyridine ring in nicotine.

D. Anderson, D. Garvey, N. Lin, 1994, Journal of medicinal chemistry.

Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.

D. Donnelly-roberts, S. Arneric, C. Briggs, 1998, Journal of medicinal chemistry.

Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice.

D. Donnelly-roberts, S. Arneric, J. Sullivan, 1998, Bioorganic & medicinal chemistry letters.